Directory

← Back to Sleep Domain

Find­ing the right device, clin­ic, or spe­cial­ist should not mean guess­ing. This direc­to­ry lists sleep-indus­try com­pa­nies and providers — wear­ables, diag­nos­tics, clin­ics, phar­ma, researchers — with stan­dard­ized pro­files cov­er­ing prod­ucts, FDA sta­tus, and the research behind them.

Every list­ing is meant to be check­able, not just a mar­ket­ing page. Com­pa­nies keep their own pro­files cur­rent, so what you see stays accu­rate. It is how the sleep indus­try should have been orga­nized from the start.

Not sure which con­di­tion you’re deal­ing with? Start with Sleep & Health. Want the research a list­ing’s claims are based on? See Research. And if you’ve hit a wall with insur­ance or access, read what we’re advo­cat­ing for in Advo­ca­cy.

Browse the Directory

All  |  Asso­ci­a­tions, Non­prof­its & Advo­ca­cy (14)  |  Diag­nos­tics, Test­ing & Sleep Labs (31)  |  Edu­ca­tion, Media & Pub­lish­ing (9)  |  Med­ical Devices & Equip­ment (68)  |  Nutri­tion & Well­ness (1)  |  Oth­er Exhibitors (1)  |  Phar­ma­ceu­ti­cals & Biotech (14)  |  Research, CROs & Clin­i­cal Tri­als (3)  |  Soft­ware & Dig­i­tal Health (8)  |  Staffing, Con­sult­ing & Busi­ness Ser­vices (3)

Alkermes, Inc.

Glob­al bio­phar­ma­ceu­ti­cal com­pa­ny devel­op­ing med­i­cines in neu­ro­science, includ­ing inves­ti­ga­tion­al ther­a­pies for nar­colep­sy and idio­path­ic hyper­som­nia.

Alkermes, Inc. (Medical)

Glob­al bio­phar­ma­ceu­ti­cal com­pa­ny devel­op­ing med­i­cines in neu­ro­science, includ­ing inves­ti­ga­tion­al ther­a­pies for nar­colep­sy and idio­path­ic hyper­som­nia.

Apnimed

Late-stage clin­i­cal phar­ma­ceu­ti­cal com­pa­ny devel­op­ing nov­el ther­a­pies for obstruc­tive sleep apnea and oth­er sleep-relat­ed dis­eases.

Axsome Therapeutics

Bio­phar­ma­ceu­ti­cal com­pa­ny devel­op­ing and com­mer­cial­iz­ing ther­a­pies for cen­tral ner­vous sys­tem dis­or­ders, includ­ing nar­colep­sy and exces­sive day­time sleepi­ness.

Axsome Therapeutics (Medical)

Bio­phar­ma­ceu­ti­cal com­pa­ny devel­op­ing and com­mer­cial­iz­ing ther­a­pies for cen­tral ner­vous sys­tem dis­or­ders, includ­ing nar­colep­sy and exces­sive day­time sleepi­ness.

Centessa Pharmaceuticals

Clin­i­cal-stage phar­ma­ceu­ti­cal com­pa­ny devel­op­ing med­i­cines for seri­ous dis­eases, includ­ing orex­in-ago­nist pro­grams for sleep-wake dis­or­ders.

Harmony Biosciences

Bio­phar­ma­ceu­ti­cal com­pa­ny focused on ther­a­pies for rare neu­ro­log­i­cal dis­eases, with a foun­da­tion in sleep-wake dis­or­ders.

Harmony Biosciences

Bio­phar­ma­ceu­ti­cal com­pa­ny focused on ther­a­pies for rare neu­ro­log­i­cal dis­eases, with a foun­da­tion in sleep-wake dis­or­ders.

Jazz Pharmaceuticals, Inc.

Bio­phar­ma­ceu­ti­cal com­pa­ny devel­op­ing and com­mer­cial­iz­ing med­i­cines in neu­ro­science and oncol­o­gy, includ­ing ther­a­pies for nar­colep­sy and exces­sive day­time sleepi­ness.

Neurovalens

Devel­ops non-inva­sive neu­rostim­u­la­tion prod­ucts, includ­ing Mod­ius Sleep for the treat­ment of chron­ic insom­nia.

Sleep Reset

A vir­tu­al sleep clin­ic pro­vid­ing per­son­al­ized, sci­ence-backed care for insom­nia and sleep apnea, includ­ing cog­ni­tive behav­ioral ther­a­py for insom­nia (CBT‑I).

SleepioRx by Big Health

An FDA-cleared pre­scrip­tion dig­i­tal treat­ment deliv­er­ing cog­ni­tive behav­ioral ther­a­py for insom­nia (CBT‑I) for adults with chron­ic insom­nia or insom­nia dis­or­der.

Suven Life Sciences Limited

Clin­i­cal-stage bio­phar­ma­ceu­ti­cal com­pa­ny devel­op­ing cen­tral ner­vous sys­tem ther­a­pies, includ­ing samelisant for exces­sive day­time sleepi­ness in nar­colep­sy.

Takeda

Glob­al bio­phar­ma­ceu­ti­cal com­pa­ny devel­op­ing and com­mer­cial­iz­ing med­i­cines across neu­ro­science, gas­troen­terol­o­gy, oncol­o­gy, plas­ma-derived ther­a­pies, vac­cines, and rare dis­eases.

Run a com­pa­ny on this list? Request an edit link to keep your pro­file cur­rent.